OptiNose (OPTN)
(Real Time Quote from BATS)
$1.08 USD
-0.09 (-7.69%)
Updated May 14, 2024 12:00 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Price, Consensus and EPS Surprise
OPTN 1.08 -0.09(-7.69%)
Will OPTN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for OPTN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OPTN
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
OPTN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
Will OptiNose (OPTN) Report Negative Q1 Earnings? What You Should Know
OptiNose (OPTN) Reports Q4 Loss, Lags Revenue Estimates
Other News for OPTN
OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024
OptiNose: Q1 Earnings Snapshot
Optinose Reports First Quarter 2024 Financial ResultsĀ and Recent Operational Highlights
Optinose GAAP EPS of -$0.12, revenue of $14.88M
Optinose sees 2024 XHANCE net revenue $85M-$95M